Publications
Detailed Information
Human papillomavirus type 16 E5 protein inhibits hydrogen peroxide-induced apoptosis by stimulating ubiquitin-proteasome-mediated degradation of Bax in human cervical cancer cells
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Oh, Jung-Min | - |
dc.contributor.author | Kim, Su-Hyeong | - |
dc.contributor.author | Cho, Eun-Ah | - |
dc.contributor.author | Song, Yong-Sang | - |
dc.contributor.author | Juhnn, Yong-Sung | - |
dc.contributor.author | Kim, Woo-Ho | - |
dc.date.accessioned | 2012-05-31T07:35:14Z | - |
dc.date.available | 2012-05-31T07:35:14Z | - |
dc.date.issued | 2010-03 | - |
dc.identifier.citation | CARCINOGENESIS; Vol.31 3; 402-410 | ko_KR |
dc.identifier.issn | 0143-3334 | - |
dc.identifier.uri | https://hdl.handle.net/10371/76700 | - |
dc.description.abstract | To investigate the mechanism by which the human papillomavirus (HPV) E5 protein contributes to the carcinogenesis of uterine cervical cancer, we studied the effect of HPV E5 on apoptosis of cervical cancer cells and its underlying mechanism. Expression of HPV16 E5 protein inhibited hydrogen peroxide-induced apoptosis in C-33A cervical cancer cells. E5 decreased the expression of Bax protein, and exogenous expression of Bax abolished the anti-apoptotic effect of E5. Knockdown of E5 by small interfering RNA sensitized CaSki cervical cancer cells to hydrogen peroxide-induced apoptosis with concurrent increase in Bax expression. Transient expression of E5 significantly increased the degradation rate of Bax protein by inducing the ubiquitination. The E5-induced decrease in Bax expression was inhibited by a cyclooxygenase-2 (COX-2) inhibitor, prostaglandin E2 (PGE(2)) receptor antagonists and cyclic adenosine monophosphate-dependent protein kinase (PKA) inhibitor. Treatment with PGE(2) decreased the expression of Bax and inhibited hydrogen peroxide-induced apoptosis of C-33A cells. We concluded that HPV16 E5 protein inhibits hydrogen peroxide-induced apoptosis of cervical cancer cells by stimulating the ubiquitin-proteasome-mediated degradation of Bax protein, and the pathway involves COX-2, PGE(2) and PKA. This finding suggests the possibility that HPV 16 E5 protein contributes to cervical carcinogenesis by inhibiting apoptosis of transformed cervical epithelial cells. | ko_KR |
dc.language.iso | en | ko_KR |
dc.publisher | OXFORD UNIV PRESS | ko_KR |
dc.title | Human papillomavirus type 16 E5 protein inhibits hydrogen peroxide-induced apoptosis by stimulating ubiquitin-proteasome-mediated degradation of Bax in human cervical cancer cells | ko_KR |
dc.type | Article | ko_KR |
dc.contributor.AlternativeAuthor | 오정민 | - |
dc.contributor.AlternativeAuthor | 김수형 | - |
dc.contributor.AlternativeAuthor | 조은아 | - |
dc.contributor.AlternativeAuthor | 송용상 | - |
dc.contributor.AlternativeAuthor | 김우호 | - |
dc.contributor.AlternativeAuthor | 전용성 | - |
dc.identifier.doi | 10.1093/carcin/bgp318 | - |
dc.citation.journaltitle | CARCINOGENESIS | - |
dc.description.citedreference | Oh JM, 2009, CARCINOGENESIS, V30, P141, DOI 10.1093/carcin/bgn236 | - |
dc.description.citedreference | Yu M, 2008, BIOCHEM BIOPH RES CO, V371, P10, DOI 10.1016/j.bbrc.2008.03.122 | - |
dc.description.citedreference | Mates JM, 2008, ARCH TOXICOL, V82, P273, DOI 10.1007/s00204-008-0304-z | - |
dc.description.citedreference | Liu FT, 2008, BLOOD, V111, P2797, DOI 10.1182/blood-2007-08-110445 | - |
dc.description.citedreference | Agrawal SG, 2008, BLOOD, V111, P2790, DOI 10.1182/blood-2007-10-110460 | - |
dc.description.citedreference | Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308 | - |
dc.description.citedreference | Maufort JP, 2007, CANCER RES, V67, P6106, DOI 10.1158/0008-5472.CAN-07-0921 | - |
dc.description.citedreference | Woodman CBJ, 2007, NAT REV CANCER, V7, P11, DOI 10.1038/nrc2050 | - |
dc.description.citedreference | Kim MJ, 2006, PHARMACOL RES, V54, P261, DOI 10.1016/j.phrs.2006.05.006 | - |
dc.description.citedreference | Chipuk JE, 2006, CELL DEATH DIFFER, V13, P1396, DOI 10.1038/sj.cdd.4401963 | - |
dc.description.citedreference | Martin ACL, 2006, BIOCHEM SOC T, V34, P480 | - |
dc.description.citedreference | Vogt M, 2006, ONCOGENE, V25, P4009, DOI 10.1038/sj.onc.1209429 | - |
dc.description.citedreference | Fecker LF, 2006, J INVEST DERMATOL, V126, P1366, DOI 10.1038/sj.jid.5700192 | - |
dc.description.citedreference | Miquel C, 2005, AM J CLIN PATHOL, V123, P562, DOI 10.1309/JQ2X3RV3L8F9TGYW | - |
dc.description.citedreference | GENTHERWILLIAMS SM, 2005, CANCER RES, V65, P6534 | - |
dc.description.citedreference | Pelicano H, 2004, DRUG RESIST UPDATE, V7, P97, DOI 10.1016/j.drup.2004.01.004 | - |
dc.description.citedreference | Zhang HG, 2004, ONCOGENE, V23, P2009, DOI 10.1038/sj.onc.1207373 | - |
dc.description.citedreference | Kabsch K, 2004, INTERVIROLOGY, V47, P48, DOI 10.1159/000076642 | - |
dc.description.citedreference | Newmeyer DD, 2003, CELL, V112, P481 | - |
dc.description.citedreference | Sultana H, 2003, ANN ONCOL, V14, P214, DOI 10.1093/annonc/mdg071 | - |
dc.description.citedreference | Kabsch K, 2002, J VIROL, V76, P12162, DOI 10.1128/JVI.76.23.12162-12172.2002 | - |
dc.description.citedreference | Cho YS, 2002, CLIN CANCER RES, V8, P607 | - |
dc.description.citedreference | Kabsch K, 2002, ONCOGENE, V21, P947 | - |
dc.description.citedreference | ZUR HH, 2002, NAT REV CANCER, V2, P342 | - |
dc.description.citedreference | Zhang BY, 2002, J VIROL, V76, P220, DOI 10.1128/JVI.76.1.220-231.2002 | - |
dc.description.citedreference | Munger K, 2001, ONCOGENE, V20, P7888 | - |
dc.description.citedreference | Choi WS, 2001, J NEUROCHEM, V77, P1531 | - |
dc.description.citedreference | Tomakidi P, 2000, EUR J CELL BIOL, V79, P407 | - |
dc.description.citedreference | Li BY, 2000, P NATL ACAD SCI USA, V97, P3850 | - |
dc.description.citedreference | Oetke C, 2000, ARCH VIROL, V145, P2183 | - |
dc.description.citedreference | Harima Y, 1998, J CANCER RES CLIN, V124, P503 | - |
dc.description.citedreference | Daniel PB, 1998, ANNU REV NUTR, V18, P353 | - |
dc.description.citedreference | Gorman A, 1997, FEBS LETT, V404, P27 | - |
dc.description.citedreference | Rampino N, 1997, SCIENCE, V275, P967 | - |
dc.description.citedreference | Stoppler MC, 1996, VIROLOGY, V223, P251 | - |
dc.description.citedreference | KRAJEWSKI S, 1995, CANCER RES, V55, P4471 | - |
dc.description.citedreference | SIADATPAJOUH M, 1994, J HISTOCHEM CYTOCHEM, V42, P1503 | - |
dc.description.citedreference | CIECHANOVER A, 1994, CELL, V79, P13 | - |
dc.description.citedreference | CONRAD M, 1993, J VIROL, V67, P6170 | - |
dc.description.citedreference | STRAIGHT SW, 1993, J VIROL, V67, P4521 | - |
dc.description.citedreference | OLTVAI ZN, 1993, CELL, V74, P619 | - |
dc.description.citedreference | PIM D, 1992, ONCOGENE, V7, P27 | - |
dc.description.citedreference | LEECHANACHAI P, 1992, ONCOGENE, V7, P19 | - |
dc.description.citedreference | SCHEFFNER M, 1990, CELL, V63, P1129 | - |
dc.description.citedreference | YEE C, 1985, AM J PATHOL, V119, P361 | - |
dc.description.citedreference | RHIM JS, 1985, SCIENCE, V227, P1250 | - |
dc.description.tc | 4 | - |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.